By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Verona Pharma 

Suite 21 - Alpha House
100 Borough High Street
London    SE1 1LB  United Kingdom
Phone: 44-0-20-7863-3300 Fax: 44-0-20-7863-3314


SEARCH JOBS


Industry
Pharmaceutical

Segment
Life Sciences





Company News
Appointment Of Dr Kenneth Newman As Chief Medical Officer And Incorporation Of Verona Pharma (VRP.L) 12/17/2014 10:03:24 AM
Verona Pharma (VRP.L) Release: Appointment Of Dr. David Ebsworth As Non-Executive Chairman Of The Board Of Directors 11/24/2014 11:54:18 AM
Verona Pharma (VRP.L) Announces Venture And Innovation Award From The Cystic Fibrosis Trust 11/3/2014 12:50:50 PM
Verona Pharma (VRP.L) Release: Appointment Of Biresh Roy As CFO And Member Of The Board Of Directors 9/30/2014 9:09:22 AM
Verona Pharma (VRP.L) New Data Supports RPL554 As A Potential Novel Cystic Fibrosis Therapy 9/29/2014 11:08:25 AM
Verona Pharma (VRP.L) Release: Interim Results For The Six Months Ended 30 June 2014 9/11/2014 9:49:14 AM
Verona Pharma (VRP.L) Release: RPL554 Presentations At ERS Congress Highlight Its Valuable Potential In Combination Therapy For COPD And Other Respiratory Diseases 9/9/2014 9:16:58 AM
Verona Pharma (VRP.L)'s VRP700 Did Not Meet Primary Goals In Phase 2a Trial 6/23/2014 10:31:55 AM
Verona Pharma Data Highlighting Synergistic Action Of Novel Dual PDE3/4 Inhibitor RPL554 With Muscarinic Receptor Antagonists And Beta-Adrenoceptor Agonists In Reversing Bronchoconstriction Presented At American Thoracic Society International Conference 5/21/2014 10:53:36 AM
Verona Pharma Release: RPL554 Presentation At The Asthma And COPD Conference, London, 3 April 2014 4/3/2014 2:08:14 PM
12345
//-->